enVVeno Medical (NVNO) Prepaid Assets (2017 - 2026)
enVVeno Medical's (NVNO) quarterly Prepaid Assets came in at $559000.0 in Q1 2026, up 3.9% year-on-year from $538000.0 in Q1 2025, and down 8.96% quarter-over-quarter from $614000.0 in Q4 2025.
enVVeno Medical (NVNO) Prepaid Assets (2017 - 2026) Analysis & Trends
enVVeno Medical's Prepaid Assets history runs 10 years deep, the most recent figure standing at $559000.0 for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 3.9% year-over-year to $559000.0 in Q1 2026; TTM through Mar 2026 was $559000.0, a 3.9% increase from a year earlier, with the FY2025 full-year figure at $614000.0, up 5.68% from the prior year.
- Prepaid Assets retreated to $559000.0 in Q1 2026 per NVNO's latest filing, from $614000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $672000.0 in Q3 2024 and bottomed at $239000.0 in Q2 2022.
- The 5-year median for Prepaid Assets is $469000.0 (2024), against an average of $456882.4.
- Across the five-year window, Prepaid Assets tumbled 40.2% in 2022 and soared 75.82% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $392000.0 in 2022, then jumped by 30.36% to $511000.0 in 2023, then gained by 13.7% to $581000.0 in 2024, then increased by 5.68% to $614000.0 in 2025, then declined by 8.96% to $559000.0 in 2026.
- Per Business Quant, the three latest NVNO Prepaid Assets figures stand at $559000.0 (Q1 2026), $614000.0 (Q4 2025), and $547000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 559,000.00 |
| Dec 31, 2025 | 614,000.00 |
| Sep 30, 2025 | 547,000.00 |
| Jun 30, 2025 | 462,000.00 |
| Mar 31, 2025 | 538,000.00 |
| Dec 31, 2024 | 581,000.00 |
| Sep 30, 2024 | 672,000.00 |
| Jun 30, 2024 | 469,000.00 |
| Mar 31, 2024 | 306,000.00 |
| Dec 31, 2023 | 511,000.00 |
| Sep 30, 2023 | 520,000.00 |
| Jun 30, 2023 | 352,000.00 |
| Mar 31, 2023 | 312,000.00 |
| Dec 31, 2022 | 392,000.00 |
| Sep 30, 2022 | 381,000.00 |
| Jun 30, 2022 | 239,000.00 |
| Mar 31, 2022 | 312,000.00 |
| Dec 31, 2021 | 312,000.00 |
| Sep 30, 2021 | 310,046.00 |
| Jun 30, 2021 | 399,685.00 |